IMS: Net loss reduced, equity ratio strengthened, and Efemia sales surged in key European markets

About this update from Invent Medic Sweden Ab

Net loss narrowed and equity ratio improved year-over-year, with strong sales momentum for Efemia in France and NHS listing in the UK. Cash position strengthened following a rights issue, supporting continued growth and product development.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Invent Medic Sweden Ab